CAS · 864070-37-1
Product Overview
Bms-511926 is a high-purity pharmaceutical-intermediates supplied for industrial and specialty chemical applications. Contact our team for specifications, packaging options and lead times.
Product Specifications
| Appearance | White to yellow solid |
|---|---|
| Purity | 99% min |
| Identification | The retention time of the major peak of the sample solution corresponds to that of the standard solution |
| Water | 1% max |
| Residue on Ignition | 0.5% max |
| Related Substances | Individual impurities: 0.5% max Total impurities: 1% max |
Applications
BMS-511926 is a selective antagonist of the cannabinoid CB1 receptor, making it a valuable tool in pharmacological research and drug discovery. It is primarily applied in the investigation of obesity, metabolic syndrome, and type 2 diabetes due to its ability to modulate appetite and energy balance. Researchers also use it to study the endocannabinoid system and its role in neurological conditions, including anxiety, addiction, and neurodegenerative disorders. In preclinical studies, BMS-511926 has been applied as a model compound to evaluate the therapeutic potential of CB1 antagonists in cardiovascular, hepatic, and metabolic health.
Benefits
The benefits of BMS-511926 lie in its potency and selectivity, which allow researchers to precisely study CB1 receptor pathways without significant off-target effects. This precision contributes to a clearer understanding of the endocannabinoid system and its therapeutic implications. It offers strong potential in addressing obesity and related metabolic disorders by targeting appetite regulation and energy expenditure mechanisms. Moreover, its pharmacological profile provides a valuable reference compound for developing safer, more effective CB1 modulators with fewer adverse effects.
Conclusion
BMS-511926 serves as an important compound in advancing research into the endocannabinoid system and its therapeutic possibilities. Its applications in metabolic and neurological studies highlight its relevance in addressing complex health challenges such as obesity, diabetes, and addiction. With its selectivity and efficacy, BMS-511926 continues to contribute significantly to drug discovery efforts, paving the way for the development of innovative treatments that harness the potential of CB1 receptor modulation.
Previous
2-Amino-5-chlorobenzoic Acid丨CAS 635-21-2
Next